Based at the Addictions Dept (and SLaM’s Lambeth Addictions service and the KHP Clinical Trial Facility [CTF]), a Research Assistant is sought to have a pivotal role in the running of a commercially sponsored Phase 2a (safety and efficacy) trial of psychedelic-assisted (5-Meo-DMT) relapse-prevention oriented cognitive behavioural treatment for alcohol use disorder. Reporting to the study lead investigator, the purpose of the role will be to support the trial chief and investigator team, and liaise with the sponsor (Beckley PsyTech) to ensure the efficient, safe and effective running of the study. In accordance with Good Clinical Practice, the post-holder will be responsible for scheduling (and supporting clinical staff involved in) clinical screening, CBT session scheduling, booking of medication dosing at the CTF, management of the study’s electronic (audio and video) data capture system, the trial master file, delegation log, and supporting the sponsor’s monitoring arrangements.
The post-holder will be required to attend meetings of research partners and maintain and report accurate study reports on activity.
This post will be offered on a full-time, fixed-term contract to 31st March 2024
Key responsibilities
- Supporting the investigators to ensure efficient participant screening process
- Supporting study participants (payments, schedule, links with clinical care)
- Management of the electronic data capture system
- Management of paper case record forms
- Liaison with study sponsor
- Liaison with the CTF
- Supporting media recruitment of participants
The above list of responsibilities may not be exhaustive, and the post holder will be required to undertake such tasks and responsibilities as may reasonably be expected within the scope and grading of the post.
Skills, knowledge, and experience
Essential criteria
1. Masters or doctoral degree qualification
2. Experience of conducting clinical research (phase I, II or III)
3. Experience of working with electronic data capture systems
Desirable criteria
1. Experience of conducting clinical research (phase I, II or III) in the addictions
2. Knowledge of psychedelic-assisted treatment
3. Experience of medication intervention trials
4. Experience of psychosocial intervention trials
This post is subject to an Occupational Health clearance.
